Galectin‐3 and risk of atrial fibrillation: A systematic review and meta‐analysis
Mengqi Gong(Central South University), Tong Liu(Second Hospital of Tianjin Medical University), Christos A. Goudis(General Hospital of Serres), Gregory Y.H. Lip(Medical University of Białystok), Gary Tse(Observational & Pragmatic Research Institute), Angel Cheung(Brown University), Panagiotis Korantzopoulos(University of Ioannina), Qunshan Wang(Shanghai Jiao Tong University), Adrián Baranchuk(Population Health Research Institute), Guangping Li(Qingdao University), George Bazoukis(Evangelismos Hospital), Κonstantinos P. Letsas(Evangelismos Hospital)
Cited by 51
Related Papers
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k